These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5533294)

  • 1. Plasma insulin and metabolic study on diabetes treated with glibenclamide.
    Anderson J; Coulson R; Grassick BD; Morris BA; Thomas WD; Tomlinson RW; Woodroffe F
    Postgrad Med J; 1970 Dec; ():Suppl:36-41. PubMed ID: 5533294
    [No Abstract]   [Full Text] [Related]  

  • 2. Glibenclamide in the management of diabetes mellitus. I.
    Devlin JG; Manning K; Harty J
    J Ir Med Assoc; 1971 Apr; 64(409):197-9. PubMed ID: 5554337
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative study of glibenclamide and chlorpropamide. (Preliminary report).
    Hamblin JJ; Ismay G; Good MS; Wynne-Williams CJ; Baum G; Wilson IV
    Postgrad Med J; 1970 Dec; ():Suppl:92-4. PubMed ID: 5533305
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with glibenclamide in three diabetic clinics.
    Brearley BF; Fawcitt RA; Hirst J
    Postgrad Med J; 1970 Dec; ():Suppl:60-2. PubMed ID: 5533300
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of glibenclamide with chlorpropamide in newly diagnoeed maturity-onset diabetes.
    Gurling KJ
    Postgrad Med J; 1970 Dec; ():Suppl:66-9. PubMed ID: 5533301
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of short-term effects of glibenclamide and chlorpropamide in newly diagnosed diabetics.
    FitzGerald MG; Malino JM
    Postgrad Med J; 1970 Dec; ():Suppl:57-9. PubMed ID: 5533299
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of glibenclamide with other oral hypoglycaemic agents.
    Wetherill JH; Tunbridge RE
    Postgrad Med J; 1970 Dec; ():Suppl:88-91. PubMed ID: 5533304
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in diabetes therapy using glibenclamide and phenformin. Report from the years 1967-1970 on 323 patients].
    Beyer J; Ewald W; Kunkel W; Wolf E; Schöffling K
    Dtsch Med Wochenschr; 1971 Apr; 96(17):728-33. PubMed ID: 5552854
    [No Abstract]   [Full Text] [Related]  

  • 9. Diurnal blood sugar levels and clinical experience during glibenclamide therapy.
    O'Sullivan DJ
    Postgrad Med J; 1970 Dec; ():Suppl:46-9. PubMed ID: 5533296
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical experience with glibenclamide in 300 diabetics.
    Beyer J; Schöffling K
    Postgrad Med J; 1970 Dec; ():Suppl:78-83. PubMed ID: 5500516
    [No Abstract]   [Full Text] [Related]  

  • 11. Glibenclamide for secondary failure of other sulphonylureas.
    Stowers JM
    Postgrad Med J; 1970 Dec; ():Suppl;63-5. PubMed ID: 5500519
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preliminary results with a new oral antidiabetic drug of the sulfanylurea series: glibenclamide or HB 419].
    Marocco F; Patrito G
    Minerva Med; 1970 Dec; 61(97):5525-42. PubMed ID: 5494124
    [No Abstract]   [Full Text] [Related]  

  • 13. Twenty-four-hour urinary glucose levels during tolbutamide and glibenclamide therapy.
    Cohen H; Clyne JR
    Postgrad Med J; 1970 Dec; ():Suppl:50-2. PubMed ID: 5533297
    [No Abstract]   [Full Text] [Related]  

  • 14. Circadian variation of glucose, insulin and free fatty acids during the long-term use of oral hypoglycaemic agents in diabetes mellitus with special reference to glibenclamide.
    Hadden DR; Bhatia SK; Rigas A; Weaver JA; Montgomery DA
    Postgrad Med J; 1970 Dec; ():Suppl:53-7. PubMed ID: 5533298
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of glibenclamide and chlorpropamide in the treatment of non-obese maturity onset diabetics.
    Johnston AT; Ireland JT
    Postgrad Med J; 1970 Dec; ():Suppl:98-100. PubMed ID: 5500517
    [No Abstract]   [Full Text] [Related]  

  • 16. [Glybenclamide and its place among sulfanylureas in the treatment of diabetes mellitus].
    Cabezas Cerrato J; Fernández-Cruz A; Fernández-Cruz A
    Rev Clin Esp; 1970 May; 117(4):375-86. PubMed ID: 5471527
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral differential therapy of diabetes mellitus].
    Mehnert H
    Dtsch Med Wochenschr; 1970 Aug; 95(35):1795-6. PubMed ID: 5451987
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of Daonil--a new sulphonylurea derivative].
    Nowotna-Walcowa R; Rozyńska E
    Pol Tyg Lek; 1971 Jan; 26(2):65-7. PubMed ID: 5101252
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of glibenclamide in diabetes mellitus.
    Luntz GR
    Postgrad Med J; 1970 Dec; ():Suppl:84-7. PubMed ID: 5533303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.